Ubs Group Ag Decibel Therapeutics, Inc. Transaction History

Ubs Group Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$2.41 - $4.81 $4,070 - $8,124	1,689 Added 3671.74%	1,735 $6,000
Q1 2023 May 12, 2023	BUY	$2.08 - $4.79 $95 - $220	46 New	46 $0
Q2 2022 Aug 10, 2022	BUY	$1.85 - $4.21 $2,782 - $6,331	1,504 New	1,504 $6,000
Q1 2022 May 16, 2022	SELL	$2.83 - $5.03 $268 - $477	-95 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.57 - $8.58 $434 - $815	95 New	95 $0
Q3 2021 Nov 15, 2021	SELL	$6.6 - $9.04 $3,392 - $4,646	-514 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$6.39 - $11.51 $15,981 - $28,786	-2,501 Reduced 82.95%	514 $4,000
Q1 2021 May 12, 2021	BUY	$10.56 - $19.9 $31,838 - $59,998	3,015 New	3,015 $34,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.